Low-dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin-3 in gynecologic cancers.
Ohgami
Tatsuhiro
T
Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. gamitatu@kyudai.jp
Kato
Kiyoko
K
Kobayashi
Hiroaki
H
Sonoda
Kenzo
K
Inoue
Takafumi
T
Yamaguchi
Shin-ichiro
S
Yoneda
Tomoko
T
Wake
Norio
N